IndusInd Bank shares hit 15% lower circuit after Q2 earnings disappoint – Here is what’s worrying investors

Private sector lender IndusInd Bank plunges 15% to hit intra-day low of Rs 1088.05 on NSE after posting its Q2 FY25 earnings, with a notable 39% year-over-year (YoY) decline in net profit. The bank’s latest results, released Thursday, also show moderate growth in net interest income (NII) but miss market profit expectations.

Net Profit Falls Short of Street Estimates

IndusInd Bank reported a net profit of Rs 1,325 crore for the September quarter, significantly below analysts’ expectations of Rs 2,138 crore. This figure also reflects a sharp decline from the Rs 2,181.47 crore profit recorded in Q2 FY24.

NII Growth and Margin Contraction

The bank’s net interest income increased by 5% YoY to Rs 5,347 crore. However, the net interest margin (NIM) was reported at 4.08%, a 21 basis point (bps) drop from the 4.29% margin in the same period last year and an 18 bps decline on a quarter-on-quarter (QoQ) basis.

Also Read RBL Bank shares plunge over 13% after net profit falls 24%; Should you buy the dip? Wipro shares zoom over 5% after Q2 betters estimates; is it the right time to buy? Vodafone Idea shares slide 7% to 52-week lows after DoT notice on bank guarantees Gland Pharma shares slump 3% as Goldman Sachs downgrades to ‘Sell,’ says 27% downside likely

Strong Growth in Deposits and CASA Ratios

IndusInd’s deposits surpassed the Rs 4 lakh crore mark, reaching Rs 4,12,317 crore, which represents a 15% YoY increase from Rs 3,59,548 crore. The bank’s CASA deposits rose to Rs 1,47,944 crore.

Also ReadIndusInd Bank Share Price Today Live Updates, 25 Oct, 2024: IndusInd Bank on the radar

This included Rs 52,606 crore in current account deposits and Rs 95,338 crore in savings deposits, comprising 35.87% of total deposits as of September 30, 2024.

Gross and Net NPA Ratios Show Mild Deterioration

The bank’s gross non-performing asset (NPA) ratio increased to 2.11%, up from 1.93% YoY, while the net NPA ratio rose to 0.64%, up from 0.57% in the previous year’s corresponding quarter.

Provisions and Provision Coverage Ratio

Provisions and contingencies for Q2 FY25 amounted to Rs 1,820 crore, a significant increase from Rs 974 crore in the year-ago period. The Provision Coverage Ratio (PCR) remained consistent at 70% as of September 30, 2024.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth